See you in 2023.
Thanks for joining us in person as we discussed the opportunities in Gene and Cell Therapy. We’ll see you next year at our new location, the Westin Boston Seaport District.
June 12–14, 2023 • Seaport District, Boston • In-Person
Disruptive Dozen
First Look Winners
IDG Winners
Register for 2023
Join us in person at the World Medical Innovation Forum as we bring together global leaders to assess the latest opportunities and challenges, from the investment landscape to key technology developments to manufacturing and regulatory barriers. Gain first-hand insights on medicine’s ultimate game changer.
Meet
Network in-person with the leaders who discover, invest in, and cultivate breakthroughs
Explore
Get an up close look at the research and technologies that are revolutionizing patient care
Discover
Hear about implementation of new technology and impacts on global markets and the regulatory environment
2022 Stats
200
CEOs, industry, investment, and senior government leaders alongside Harvard faculty
12
MD-led focused sessions on key GCT/biotech topics
16
First Look sessions featuring high potential new Mass General Brigham GCT technologies
1500
In person attendees — network, share and learn with experts across industry and academia
Enhanced investment and market focused panels hosted by our partner, Bank of America
Who Attends
Investors
Industry Leaders
Engage with peers from across the GCT and machine learning ecosystem. Meet other executives, decision-makers, and business leaders from health care, pharma, medical devices, and biotech.
Clinicians and Investigators
The one event where physician and clinical leaders connect with peers across the medical landscape. Attend plenary panels, networking events, and fireside chats to capture insight into how GCT and other technology is enhancing the care continuum.
Government Leaders
Join leaders from across the spectrum of government roles. Learn about the priorities of officials who are leading government agencies.
Payers
Connect with the executives who are determining how gene and cell therapy will be reimbursed.
